AUNA (AUNA) Q1 2025: Peru EBITDA Margin Expands 1.7pts as Mexico Faces Physician Integration Headwind
Peru’s high-complexity services and efficiency gains drove margin expansion, offsetting Mexico’s operational reset as AUNA’s physician integration strategy hit resistance. Colombia’s risk-sharing model continues to stabilize cash flow, but ongoing payer risk and conservative guidance signal a cautious stance on near-term growth visibility.
Summary
- Margin Expansion in Peru: Operating leverage and higher complexity services pushed Peru’s EBITDA margin higher, demonstrating the strength of AUNA’s integrated model.
- Mexico Reset Delays Growth: Physician and supplier realignment disrupted volumes, exposing cultural and operational hurdles in model rollout.
- Colombia Cash Flow Stabilizes: Risk-sharing and payer diversification are improving payment cycles, but provisions and regulatory risk persist.
Performance Analysis
AUNA’s Q1 results reflected a mixed operating environment across its core geographies. Peru delivered standout performance, with revenue up 10% and adjusted EBITDA rising 19%, powered by increased capacity utilization and a focus on high-complexity, higher-margin services. The vertically integrated approach—combining healthcare plans and provider operations—continues to yield margin expansion, with Peru’s EBITDA margin improving by 1.7 percentage points.
Mexico, however, experienced a 4% revenue decline and a 5% dip in adjusted EBITDA (FX-neutral), as the company’s push to implement the “AUNA way”—a value-based care model disrupting traditional supplier-physician relationships—led to a sharp, though transitional, drop in physician productivity and patient volumes. Colombia posted modest 5% revenue growth, driven by risk-sharing contracts, but margins were compressed by increased impairment provisions and the absence of prior-year retroactive price adjustments.
- Peru’s Outperformance: High-complexity services and efficiency initiatives drove both top-line and margin gains, offsetting regional softness.
- Mexico’s Disruption: Operational reset to align physician incentives with the AUNA model led to temporary volume and productivity declines.
- Colombia’s Risk Management: Payment flows improved through risk-sharing and payer diversification, but provisions continued to pressure the bottom line.
Despite a 15% reduction in cash, AUNA maintained positive adjusted net income for a fifth consecutive quarter, supported by lower interest expense and disciplined CapEx. Organic free cash flow, excluding acquisition-related amortizations, reached 59 million soles.
Executive Commentary
"Despite the quarter's operational setbacks in Mexico, the underlying fundamentals of our healthcare platform are still very solid, and we are confident about recovering our growth momentum in Mexico as the year progresses. Our strategic direction has not changed, and we remain excited about our own admit to long-term earnings potential."
Susan Zamora, Executive Chairman and President
"Peru's 10% revenue increase was mainly driven by higher surgery volumes and improved pricing during the quarter, which you also see reflected in higher capacity utilization. At OncoSalud, our health plans business in Peru, revenue was driven by annual inflation price adjustments and a 10% increase in plan memberships."
Giselle Remy, Chief Financial Officer and Executive Vice President
Strategic Positioning
1. Peru as Margin Engine
Peru’s mature, vertically integrated model—where AUNA controls both healthcare delivery and insurance—produced robust margin expansion and operational leverage. The focus on high-complexity services, which generate superior profitability compared to bed occupancy alone, is enabling sustainable earnings growth. Efficiency programs initiated last year continue to unlock incremental value, and the model’s success in Peru is seen as a blueprint for other markets.
2. Mexico’s Physician Integration Challenge
Efforts to realign physician and supplier economics with the AUNA way disrupted established practices, resulting in lower productivity and lost volumes. Leadership acknowledged underestimating the economic impact on physicians, and has shifted to a more gradual, supportive integration process. Early signs of volume recovery are emerging, but full normalization will take time, underscoring the complexity of transforming entrenched healthcare delivery models in Mexico.
3. Colombia’s Risk-Sharing and Payer Diversification
Colombia’s operational focus has pivoted to risk mitigation and cash flow stability. The company is actively increasing the share of revenues under risk-sharing contracts (targeting 30% by year-end, up from 20% currently), which provide upfront payments and stable margins for high-complexity services. Diversifying away from government-intervened payers is reducing exposure to regulatory and payment risk, though impairment provisions and cautious revenue recognition remain necessary.
4. Oncology Platform Expansion
OncoSalud, AUNA’s oncology-focused health plan, is expanding its footprint in Mexico, with national network agreements secured in Mexico City, Guadalajara, and soon Tijuana. The integration of Opción Oncología, a center of excellence, is central to building a differentiated, high-margin oncology platform. Early client pipeline signals strong demand for comprehensive, mono-risk insurance products in oncology, a key future growth lever.
Key Considerations
This quarter highlights the operational complexity of scaling a disruptive healthcare model across diverse Latin American markets. Investors should weigh the durability of Peru’s margin engine against the transitional headwinds in Mexico and the evolving risk landscape in Colombia.
Key Considerations:
- Mexico Integration Hurdles: Physician resistance to new supplier controls is proving a significant, though likely temporary, drag on volumes and productivity.
- Peru’s Model Maturity: The integrated platform’s ability to deliver high-complexity services at scale is a core competitive advantage, with further margin upside possible as utilization rises.
- Colombia Payment Risk: While risk-sharing contracts are improving cash visibility, ongoing provisions and regulatory overhang limit near-term earnings clarity.
- Oncology Growth Optionality: Rapid expansion of OncoSalud’s network in Mexico could unlock a differentiated, high-margin growth avenue if execution remains on track.
Risks
Execution risk remains high in Mexico, where physician and supplier alignment is critical for restoring volumes and margin trajectory. Colombia’s regulatory and payer environment continues to require elevated provisioning, and any deterioration in payment cycles could further pressure cash flow. Macro volatility, FX swings, and healthcare sector fragmentation all add to the operational risk profile, making guidance conservative and visibility limited.
Forward Outlook
For Q2 and the remainder of 2025, AUNA refrained from providing formal consolidated guidance, citing ongoing recovery efforts in Mexico and payer risk in Colombia.
- CapEx is expected to remain at or below $50 million for the year.
- Effective tax rate projected to rise to approximately 38% due to intercompany payments and deferred tax benefits.
Management emphasized:
- Focus on restoring volume growth in Mexico through gradual physician integration and expanded high-complexity services.
- Continued expansion of risk-sharing contracts in Colombia to further stabilize cash flow and reduce exposure to intervened payers.
Takeaways
AUNA’s Q1 revealed both the power and the challenge of scaling a vertically integrated, value-based care model across Latin America.
- Peru Margin Engine: The mature Peru business continues to demonstrate scalable profitability, validating the integrated model’s potential in other markets.
- Mexico Transition Risk: Operational setbacks from physician integration are a reminder of the cultural and economic friction inherent in healthcare transformation, but early recovery signals are encouraging.
- Future Watchpoint: Investors should monitor Mexico’s volume recovery pace, Colombia’s risk-sharing penetration, and the ramp of OncoSalud’s national platform as key drivers of medium-term upside.
Conclusion
AUNA’s Q1 was a story of margin resilience in Peru offsetting transitional turbulence in Mexico and ongoing risk management in Colombia. The company’s long-term thesis—scaling a disruptive, integrated healthcare model—remains intact, but execution risk and market complexity will continue to drive earnings volatility and require close monitoring.
Industry Read-Through
AUNA’s experience underscores the operational and cultural hurdles facing healthcare consolidators in Latin America, particularly when shifting from fee-for-service to value-based care models. Margin expansion via high-complexity services and vertical integration is a key competitive lever, but success requires careful stakeholder management and gradual implementation. Risk-sharing contracts and payer diversification are increasingly critical in markets with regulatory and payment volatility, offering a template for peers navigating similar macro and sector dynamics. The rapid buildout of specialized insurance platforms, such as OncoSalud, points to growing demand for tailored, high-value health products in the region.